{"filing":{"accession_number":"0001213900-26-100199","cik":"0002073340","ticker":"TLNCW","company_name":"Talon Capital Corp.","form":"8-K","filing_date":"2026-09-15","report_date":"2026-09-09","primary_document":"ea0305549-8k_talon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2073340/000121390026100199/ea0305549-8k_talon.htm"},"events":[{"id":33698,"run_id":30998,"accession_number":"0001213900-26-100199","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Dr. Victoria Ivashina as an independent director and audit committee member, effective September 11, 2026. While the disclosure includes compensatory elements (share transfer at $0.003/share and standard director indemnity agreement), the principal disclosed action is the appointment of a new director to the board and audit committee. The extensive biographical detail and independence determination underscore the materiality of this governance change.","company_name":"Talon Capital Corp.","ticker":"TLNCW","filing_date":"2026-09-15","form":"8-K","submitted_at":null,"items":[{"id":37214,"accession_number":"0001213900-26-100199","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. Victoria Ivashina as an independent director and audit committee member, effective September 11, 2026. While the disclosure includes compensatory elements (share transfer at $0.003/share and standard director indemnity agreement), the principal disclosed action is the appointment of a new director to the board and audit committee. The extensive biographical detail and independence determination underscore the materiality of this governance change.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T21:11:54.494089+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37214,"accession_number":"0001213900-26-100199","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. Victoria Ivashina as an independent director and audit committee member, effective September 11, 2026. While the disclosure includes compensatory elements (share transfer at $0.003/share and standard director indemnity agreement), the principal disclosed action is the appointment of a new director to the board and audit committee. The extensive biographical detail and independence determination underscore the materiality of this governance change.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T21:11:54.494089+00:00","company_name":"Talon Capital Corp.","ticker":"TLNCW","filing_date":"2026-09-15"}]}